Issuance of Stock Acquisition Rights to Directors and Other Officers
First written in FY2017-Q3. 11 of 16 entries say "Advanced", first in FY2018-Q3. Latest entry: FY2024.
6 other companies' latest entry also says "Dropped".
- FY2024DroppedAnnual report
「At the 61st Annual General Meeting of Shareholders held on 15 June 2023, the Company resolved to introduce a restricted stock compensation plan and abolish its stock option plan. Accordingly, no new stock acquisition rights will be allocated for the stock option plan going forward.」
The theme concerning new issuances of stock acquisition rights for directors, officers and employees was discontinued as the Company transitioned to a restricted stock compensation plan, and it was explicitly stated that no new allocations will be made going forward. - FY2023AdvancedAnnual report
「Grant number 46th Series Stock Acquisition Rights Resolution date 16 February 2023 Category and number of grantees 93 employees of the Company and its subsidiaries Number of stock acquisition rights (units)* 1,336 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 133,600」
The Company granted 1,336 46th Series Stock Acquisition Rights, representing 133,600 underlying shares, to 93 employees, continuing and expanding the use of stock-settled stock options. - FY2023-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Based on the resolution dated 30 June 2022, the Company issued stock-settled stock options to 4 directors, consisting of 148 options representing 14,800 shares as compensation payable upon retirement and 999 options representing 99,900 shares as medium-term incentive compensation. - FY2022-Q3AdvancedAnnual report
「Stock-settled stock options as medium-term incentive compensation for employees of the Company and its subsidiaries Grant number 43rd Series Stock Acquisition Rights Resolution date 18 November 2021 Category and number of grantees 100 employees of the Company and its subsidiaries Number of stock acquisition rights (units)* 1,024 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 102,400」
Based on the resolution dated 18 November 2021, the Company issued 1,024 43rd Series Stock Acquisition Rights, representing 102,400 underlying shares, to 100 employees as medium-term incentive compensation. - FY2022-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Based on the resolution dated 24 June 2021, the Company issued stock-settled stock options to 6 directors, excluding outside directors, consisting of 150 options representing 15,000 shares as compensation payable upon retirement and 894 options representing 89,400 shares as medium-term incentive compensation. - FY2021AdvancedAnnual report
「Grant number 40th Series Stock Acquisition Rights Resolution date 12 March 2021 Category and number of grantees 94 employees of the Company and its subsidiaries Number of stock acquisition rights (units)* 995 [984]」
The Company granted 995 40th Series Stock Acquisition Rights, representing 99,500 underlying shares, to 94 employees. The use of stock-settled compensation for directors, officers and employees continues to expand. - FY2021-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Based on the resolution dated 25 June 2020, the Company issued stock-settled stock options to 5 directors, excluding outside directors, consisting of 211 options representing 21,100 shares as compensation payable upon retirement and 1,082 options representing 108,200 shares as medium-term incentive compensation. - FY2020RestatedAnnual report
「The stock options outstanding during the current consolidated fiscal year are covered, and the number of stock options is stated on an equivalent share basis.」
The Company has disclosed for the full year the balances, vesting, exercises and forfeitures of stock options for directors, officers and employees. - FY2020-Q3AdvancedAnnual report
「The share acquisition rights issued during the three-month period ended in the third quarter are as follows.」
Based on the resolution dated 17 October 2019, the Company issued stock-settled stock options to 108 employees of the Company and its subsidiaries as medium-term incentive compensation, totaling 1,751 options representing 175,100 underlying shares. The exercise period runs from 1 November 2022 to 31 October 2029. - FY2020-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Based on the resolution dated 20 June 2019, the Company issued stock-settled stock options to 5 directors, consisting of 181 options (18,100 shares) as compensation payable upon retirement, and to 4 directors, consisting of 764 options (76,400 shares) as medium-term incentive compensation. - FY2019RestatedAnnual report
「The stock options outstanding during the current consolidated fiscal year are covered, and the number of stock options is stated on an equivalent share basis.」
The Company has disclosed for the full year the balances, vesting, exercises and forfeitures of stock options for directors, officers and employees, including grants made in 2018. - FY2019-Q3AdvancedAnnual report
「The share acquisition rights issued during the three-month period ended in the third quarter are as follows.」
The Company issued stock-settled stock options to 101 employees of the Company and its subsidiaries as medium-term incentive compensation, consisting of 1,680 options representing 168,000 underlying shares. The exercise period runs from 2 November 2021 to 1 November 2028. - FY2019-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Based on the resolution dated 21 June 2018, the Company issued stock-settled stock options to 4 directors, excluding outside directors, consisting of 121 options (12,100 shares) as compensation payable upon retirement and 775 options (77,500 shares) as medium-term incentive compensation. - FY2018RestatedAnnual report
「The stock options outstanding during the current consolidated fiscal year are covered, and the number of stock options is stated on an equivalent share basis.」
The Company has disclosed for the full year the balances, exercises and forfeitures of stock options for directors, officers and employees, including grants made in October and November 2017. - FY2018-Q3AdvancedAnnual report
「The share acquisition rights issued during the three-month period ended in the third quarter are as follows.」
The Company issued 3 categories totaling 2,557 stock acquisition rights, representing a total of 255,700 underlying shares, as grants made in October and November 2017. - FY2017-Q3First statedAnnual report
「The share acquisition rights issued during the three-month period ended in the third quarter are as follows.」
Based on the resolution dated 15 September 2016, the Company issued 3 categories totaling 3,903 stock acquisition rights as grants made in October 2016, representing a total of 390,300 underlying shares. Depending on the category, the exercise period runs from 4 October 2016 to 3 October 2046, or from 3 October 2019 to 2 October 2026.